Organic Cherry Fruit Spread
MRT 176 Panel Triggers Identified
Clinical Product Assessment
MRT Safety Assessment
This product contains 3 MRT-tested substances: Cherry, Cane Sugar, and Lemon. Per analysis rules, the presence of 3 or more triggers classifies the product as high risk, making it unsuitable for early elimination phases and requiring practitioner guidance for reintroduction.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 3
- Safe Ingredients: 1
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| cherries | Cherry | Direct Match |
| sugar | Cane Sugar | Direct Match |
| lemon juice | Lemon | Direct Match |
LEAP Protocol Guidance
With 3 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 0681170317305
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Cherry is an MRT-tested fruit found in juices, preserves, baked goods, and cherry flavoring. Maraschino cherries contain additional chemical additives that may also be reactive.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Lemon is tested as a standalone citrus substance on the MRT panel. It appears in beverages, dressings, marinades, and as a flavoring agent. Distinct from citric acid sensitivity.
What This Means For Your Diet
With 3 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 3 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners